[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia]
[比较氟马替尼和伊马替尼治疗新诊断的慢性期慢性粒细胞白血病患者的疗效和严重血液学不良事件发生率]
期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2023.09.005
Zhang, X S; Liu, B C; Du, X; Zhang, Y L; Xu, N; Liu, X L; Li, W M; Lin, H; Liang, R; Chen, C Y; Huang, J; Yang, Y F; Zhu, H L; Pan, L; Wang, X D; Li, G H; Liu, Z G; Zhang, Y Q; Liu, Z F; Hu, J D; Liu, C S; Li, F; Yang, W; Meng, L; Han, Y Q; Lin, L E; Zhao, Z Y; Tu, C Q; Zheng, C F; Bai, Y L; Zhou, Z P; Chen, S N; Qiu, H Y; Yang, L J; Sun, X L; Sun, H; Zhou, L; Liu, Z L; Wang, D Y; Guo, J X; Pang, L P; Zeng, Q S; Suo, X H; Zhang, W H; Zheng, Y J; Jiang, Q
